1,470 research outputs found
The RFOFO Ionization Cooling Ring for Muons
Practical ionization cooling rings could lead to lower cost or improved
performance in neutrino factory or muon collider designs. The ring modeled here
uses realistic three-dimensional fields. The performance of the ring compares
favorably with the linear cooling channel used in the second US Neutrino
Factory Study. The normalized 6D emittance of an ideal ring is decreased by a
factor of approximately 240, compared with a factor of only 15 for the linear
channel. We also examine such \textit{real-world} effects as windows on the
absorbers and rf cavities and leaving empty lattice cells for injection and
extraction. For realistic conditions the ring decreases the normalized 6D
emittance by a factor of 49.Comment: 27 pages, 18 figures and 5 tables. Submitted to Phys. Rev. ST-A
A low power photoemission source for electrons on liquid helium
Electrons on the surface of liquid helium are a widely studied system that
may also provide a promising method to implement a quantum computer. One
experimental challenge in these studies is to generate electrons on the helium
surface in a reliable manner without heating the cryo-system. An electron
source relying on photoemission from a zinc film has been previously described
using a high power continuous light source that heated the low temperature
system. This work has been reproduced more compactly by using a low power
pulsed lamp that avoids any heating. About 5e3 electrons are collected on 1
cm^2 of helium surface for every pulse of light. A time-resolved experiment
suggests that electrons are either emitted over or tunnel through the 1eV
barrier formed by the thin superfluid helium film on the zinc surface. No
evidence of trapping or bubble formation is seen.Comment: 9 pages, 3 figures, submitted to J. Low Temp. Phy
Nanoparticulate CpG Immunotherapy in RAO- Affected Horses: Phase I and IIa Study
Background: Recurrent airway obstruction (RAO), an asthma-like disease, is 1 of the most common allergic diseases in horses in the northern hemisphere. Hypersensitivity reactions to environmental antigens cause an allergic inflammatory response in the equine airways. Cytosine-phosphate-guanosine-oligodeoxynucleotides (CpG-ODN) are known to direct the immune system toward a Th1-pathway, and away from the pro-allergic Th2-line (Th2/Th1-shift). Gelatin nanoparticles (GNPs) are biocompatible and biodegradable immunological inert drug delivery systems that protect CpG-ODN against nuclease degeneration. Preliminary studies on the inhalation of GNP-bound CpG-ODN in RAO-affected horses have shown promising results.
Objectives: The aim of this study was to evaluate the clinical and immunological effects of GNP-bound CpG-ODN in a double-blinded, placebo-controlled, prospective, randomized clinical trial and to verify a sustained effect post-treatment.
Animals and Methods: Twenty-four RAO-affected horses received 1 inhalation every 2 days for 5 consecutive administrations. Horses were examined for clinical, endoscopic, cytological, and blood biochemical variables before the inhalation regimen (I), immediately afterwards (II), and 4 weeks post-treatment (III).
Results: At time points I and II, administration of treatment rather than placebo corresponded to a statistically significant decrease in respiratory effort, nasal discharge, tracheal secretion, and viscosity, AaDO2 and neutrophil percentage, and an increase in arterial oxygen pressure.
Conclusion and Clinical Importance: Administration of a GNP-bound CpG-ODN formulation caused a potent and persistent effect on allergic and inflammatory-induced clinical variables in RAO-affected horses. This treatment, therefore, provides an innovative, promising, and well-tolerated strategy beyond conventional symptomatic long-term therapy and could serve as a model for asthma treatment in humans
Physical, chemical and kinetic factors affecting prion infectivity
The mouse-adapted scrapie prion strain RML is one of the most widely used in prion research. The introduction of a cell culture-based assay of RML prions, the scrapie cell assay (SCA) allows more rapid and precise prion titration. A semi-automated version of this assay (ASCA) was applied to explore a range of conditions that might influence the infectivity and properties of RML prions. These include resistance to freeze-thaw procedures; stability to endogenous proteases in brain homogenate despite prolonged exposure to varying temperatures; distribution of infective material between pellet and supernatant after centrifugation, the effect of reducing agents and the influence of detergent additives on the efficiency of infection. Apparent infectivity is increased significantly by interaction with cationic detergents. Importantly, we have also elucidated the relationship between the duration of exposure of cells to RML prions and the transmission of infection. We established that the infection process following contact of cells with RML prions is rapid and followed an exponential time course, implying a single rate-limiting process
Immunomodulatory asthma therapy in the equine animal model: A dose‐response study and evaluation of a long‐term effect
Introduction
Equine asthma represents a naturally occurring animal model for human allergic neutrophilic asthma. Inhalative nanoparticle‐bound cytosine‐phosphate‐guanosine (CpG‐GNP) immunotherapy, independent of specific allergens, has already shown promising clinical and immunological results in previous studies and offers the possibility to treat the underlying cause of the disease. This study analyses the relationship between dose and response, and evaluates a possible long‐term effect.
Methods
In the prospective, randomised, double‐blind clinical field study, 29 horses suffering from equine asthma received 10 inhalation treatments with either 187.5 µg CpG‐GNP (CpG single dose [CpGsd]; n = 11), 375 µg CpG‐GNP double dose (CpG double dose [CpGdd]; n = 9) (q48h for 20 days) or 1600 µg beclomethasone (n = 9) (q24h for 10 days). Each horse was examined three times: before the treatment (I), immediately after the 10 inhalations (II), and 8 weeks after the final inhalation (III). The three groups were compared according to clinical and laboratory parameters. The study examined the sustainability of the long‐term effect of the treatment after 8 weeks, as well as the tolerability of the formula as a double dose.
Results
The CpGsd resulted in a significant improvement in 82% of the parameters, the CpGdd in 72%. In the long‐term evaluation, the CpGsd showed a significant improvement in 100% of the parameters in comparison to the initial values, the CpGdd in 67%. On the immunological level, the bronchoalveolar lavage revealed a significant reduction of IL‐4, IL‐8, and interferon‐γ.
Conclusion
Both CpG groups displayed significant improvements in clinical and laboratory parameters, especially regarding the long‐term effect of CpGsd. Doubling the CpG dose did not result in any improvement in comparison to the original single dose. On the immunological level, an anti‐inflammatory, as well as an immunomodulatory effect, apart from a Th2‐dominated immune response, could be observed. This immunomodulatory inhalation treatment could indicate a new possibility for human allergic asthma therapy
Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids
Previous efforts in the prospective evaluation of individuals who experience attenuated psychotic symptoms have attempted to isolate mechanisms underlying the onset of full-threshold psychotic illness. In contrast, there has been little research investigating specific predictors of positive outcomes. In this study, we sought to determine biological and clinical factors associated with treatment response, here indexed by functional improvement in a pre-post examination of a 12-week randomized controlled intervention in individuals at ultra-high risk (UHR) for psychosis. Participants received either long-chain omega-3 (ω-3) polyunsaturated fatty acids (PUFAs) or placebo. To allow the determination of factors specifically relevant to each intervention, and to be able to contrast them, both treatment groups were investigated in parallel. Univariate linear regression analysis indicated that higher levels of erythrocyte membrane α-linolenic acid (ALA; the parent fatty acid of the ω-3 family) and more severe negative symptoms at baseline predicted subsequent functional improvement in the treatment group, whereas less severe positive symptoms and lower functioning at baseline were predictive in the placebo group. A multivariate machine learning analysis, known as Gaussian Process Classification (GPC), confirmed that baseline fatty acids predicted response to treatment in the ω-3 PUFA group with high levels of sensitivity, specificity and accuracy. In addition, GPC revealed that baseline fatty acids were predictive in the placebo group. In conclusion, our investigation indicates that UHR patients with higher levels of ALA may specifically benefit from ω-3 PUFA supplementation. In addition, multivariate machine learning analysis suggests that fatty acids could potentially be used to inform prognostic evaluations and treatment decisions at the level of the individual. Notably, multiple statistical analyses were conducted in a relatively small sample, limiting the conclusions that can be drawn from what we believe to be a first-of-its-kind study. Additional studies with larger samples are therefore needed to evaluate the generalizability of these findings
A comparison of nanoparticullate CpG immunotherapy with and without allergens in spontaneously equine asthma-affected horses, an animal model
Introduction: New therapeutic strategies to modulate the immune response of
human and equine allergic asthma are still under extensive investigation.
Immunomodulating agents stimulating T-regulatory cells offer new treatment
options beyond conventional symptomatic treatment or specific immunotherapy
for human and equine allergic airway diseases, with the goal of a homoeostatic
T-helper cell balance. The aim of this study was to evaluate the effects of a
nebulized gelatin nanoparticle-CpG formulation (CpG-GNP) with and without
specific allergens for the treatment of spontaneous allergic equine asthma as
a model for human asthma. Methods: Twenty equine asthma-affected horses were
treated either with CpG-GNP alone or CpG-GNP with allergens. Two specific
allergens were selected for each horse based on history and an in-vitro test.
Each horse received seven administrations of the respective nebulized
composition and was examined before treatment, immediately after and 6 weeks
after the treatment course. Results: Clinical parameters such as breathing
rate, indirect interpleural measurement, arterial blood gases, amount of
tracheal mucus and percentage of neutrophils and cytokines in tracheal washes
and serum samples were evaluated. Treatment with CpG-GNP alone as well as in
combinations with relevant allergens resulted in clinical improvement of nasal
discharge, breathing rate, amount of secretion and viscosity, neutrophil
percentage and partial oxygen pressure directly after and 6 weeks after
treatment. There were no significant differences between the two treatments in
clinical parameters or local cytokine profiles in the tracheal wash fluid
(IL-10, IFN-g, and IL-17). IL-4 concentrations decreased significantly in both
groups. Conclusion: Nonspecific CpG-GNP-based immunotherapy shows potential as
a treatment for equine and possibly also human allergic asthma
- …